Why scaling life sciences businesses may need a FrED™
Executive summary
Building a credible board is an important step for a life sciences business. Experienced board members can strengthen governance, challenge assumptions, build investor confidence and help a founder make better decisions.
But life sciences businesses move through demanding stages, each with different risks and priorities. From preclinical development to clinical trials, regulatory submissions, fundraising and commercial launch, progress depends on getting complex work done—not simply knowing what ought to be done.
Early-stage businesses therefore need access to people who combine sound judgement with relevant, practical experience. They need people who have navigated these milestones before and can help the founder and team work through the next challenge.
That is the thinking behind FrED™: a Fractional Executive Director who brings board-level perspective alongside hands-on support. FrED is designed to help a business make progress at the stage it is in, while keeping roles, responsibilities and governance clear.
The board-building challenge
For a founder, forming a board is a significant decision. A strong board can provide independent challenge, strategic insight, networks and reassurance to investors and other stakeholders. It can also help the business prepare for the next stage of growth.
Yet the needs of a young life sciences company are not static. A team preparing its first clinical study faces different questions from a company seeking late-stage funding or planning to launch a product. The experience that matters most changes as the business develops.
A board may be credible on paper but still leave a founder with a long list of recommendations and no additional capacity to deliver them. An early-stage company may need more than periodic advice. It may need an experienced person who can help translate strategy into priorities, open the right conversations, test plans and support the team as it grows.
That is not a call for boards to take over management. It is a recognition that, particularly in a small company, there can be a gap between high-level guidance and the practical work required to move forward.
The needs at each stage
Stage | What the business is working through | Experience that can help |
|---|---|---|
Discovery and preclinical development | Building the evidence base, validating the science, protecting intellectual property, selecting partners and deciding what to advance | Experience in research translation, development planning, IP strategy, partnering and financing early milestones |
First-in-human and early clinical development | Designing trials, selecting CROs and sites, planning recruitment, managing timelines and understanding the evidence needed for the next investment decision | Experience in clinical operations, trial design, quality systems, budgets, CRO relationships and milestone planning |
Clinical proof of concept and later development | Interpreting emerging data, refining the development strategy, preparing for larger studies and managing increasing funding requirements | Experience in clinical development, portfolio prioritisation, regulatory strategy, investor engagement and strategic partnerships |
Regulatory and market preparation | Preparing submissions, establishing compliant processes, planning manufacturing and supply, and understanding the needs of customers and health systems | Experience in regulatory affairs, quality, market access, reimbursement, supply and commercial readiness |
Launch and scale-up | Building commercial capability, expanding markets, managing growth and delivering against the business plan | Experience in go-to-market strategy, sales, operations, leadership, finance and scaling teams |
These stages are not a neat, linear sequence. Companies may revisit decisions as new data emerges, funding changes or regulatory and market conditions shift. That makes relevant, current experience especially valuable.
From advice to practical support
An experienced NED or adviser can bring excellent challenge and perspective. But where a company has a lean team, the question is often: who will help turn that perspective into action?
A founder might need support to:
pressure-test a clinical development plan and the assumptions behind it;
prepare for a regulatory milestone and coordinate the work required;
assess whether the company has the right operating capabilities and external partners;
develop a fundraising narrative grounded in credible milestones and funding needs;
sharpen a go-to-market plan, including market access and commercial priorities; or
focus the leadership team on the few actions most likely to move the business forward.
The right support will depend on the company’s stage and the individual’s expertise. Nobody can credibly claim to be the answer to every scientific, clinical, regulatory and commercial challenge. What matters is bringing the right experience into the business at the right time, and being clear about where that experience can make a difference.
What is a FrED?
FrED™, Fractional Executive Director, is a hybrid role for businesses that need more than board-level advice but may not yet need, or be ready to fund, a full-time executive appointment. A FrED™ brings an independent, experienced perspective while also providing practical support to the founder and leadership team.
The idea is simple: one hand in, two feet out. Close enough to help the business make progress; independent enough to retain perspective and challenge.
For a life sciences company, that could mean helping the founder structure a critical development plan, prepare for a funding round, bring greater rigour to execution or connect strategic priorities to the right capabilities. It may also mean recognising when specialist support is needed and helping the company find it.
FrED™ does not remove the need for good governance or a balanced board. Nor should the role blur accountability. The remit, decision rights, reporting lines and any formal director responsibilities should be agreed clearly. The aim is to complement the board and leadership team with practical experience matched to the company’s needs.
Building the board around the business
There is no single board model that suits every life sciences company. The aim is to build a mix of experience that fits the science, the stage, the funding model and the next set of milestones.
That may include NEDs who provide governance, independence and specialist insight. It may include advisers with deep expertise in a particular technical or regulatory area. And, where the founder and team need more help turning priorities into progress, it may include a FrED™.
As the business develops, its needs will change. The board and wider support around it should change too.
We created FrED™ because early-stage businesses often need more than advice and oversight. They need trusted, battle-tested people who understand the journey, are willing to roll up their sleeves and can help founders and teams move through the next stage with greater focus.
In life sciences, progress is built milestone by milestone. The right experience around the table, and alongside the team, can help a business reach those milestones faster and grow with confidence.